Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.joms.2006.06.266 | DOI Listing |
Cureus
June 2024
Oral and Maxillofacial Surgery, Sharad Pawar Dental College and Hospital, Datta Meghe Institute of Higher Education and Research, Wardha, IND.
J Craniofac Surg
October 2024
Division of Plastic Surgery, University of Florida, Gainsville, FL.
Cherubism is a rare hereditary dysplasia of the craniofacial skeleton with unpredictable course and controversial management. The authors report a case managed at the onset with limited mandibular resection and primary autogenous bone grafting, as well as staged secondary fat grafting for contour definition. Over 5 years, the patient demonstrated no recurrence of deformity except for mild hypoplasia, which was improved with fat grafting.
View Article and Find Full Text PDFRamon syndrome (OMIM #266270) was first described in a patient with cherubism, gingival fibromatosis, epilepsy, intellectual disability, hypertrichosis, and stunted growth. In 2018, Mehawej et al. described a patient with Ramon syndrome in whom a homozygous variant in ELMO2 was identified, suggesting that this gene may be the causative for this syndrome.
View Article and Find Full Text PDFArch Craniofac Surg
February 2024
Department of Plastic and Reconstructive Surgery, Inje University Ilsan Paik Hospital, Goyang, Korea.
Cherubism is a rare fibro-osseous condition characterized by bilateral expansion of the mandible and maxilla. Due to its rarity, treatment guidelines for cherubism have not been clearly established. Observation without surgical intervention is typically recommended, as cherubism often regresses spontaneously after puberty.
View Article and Find Full Text PDFJ Craniomaxillofac Surg
October 2023
Department of Oral and Maxillofacial Surgery, Rutgers School of Dental Medicine, Newark, NJ, USA.
The aim of our study was to review current concepts in targeted therapies for benign tumors of the jaw. Benign odontogenic and maxillofacial bone tumors often require radical surgery, with consequent morbidity that impacts patients' postsurgical quality of life. Currently, targeted therapies and novel nonsurgical therapeutics are being explored for management of non-resectable tumors, with the aim of avoiding surgery or minimizing surgical scope.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!